Newgiza University is a research-oriented university that aspires to be a leading example of a university built on principles of dedication and discipline, by creating a community of interdisciplinary researchers, professors and students who foster excellence and encourage innovation.
Therefore, the Research Center at Newgiza University is pleased to announce the selection of our interdisciplinary research project for funding by the Science, Technology & Innovation Funding Authority (STIFA). The project that contributes to the global response to the COVID-19 pandemic, aims to provide new insights on the route of entry of Covid-19 by FDA-approved repurposed drugs.
The project is led by Prof. Dr. Ahmed Ihab, as a Principle Investigator, and Dr. Nada El-Ekiaby, both at the School of Medicine at NGU, in collaboration with Prof. Dr. Hesham Sadek, Southwestern University, Prof. Dr. Medhat Al-Ghobashy from the School of Pharmacy at NGU and their corresponding teams.
Research uniqueness at NGU is acquired by the number of research projects in different schools and the number of interdisciplinary research projects with the corresponding staff and students involved and most importantly, the number of international peer-reviewed publications.
This project comes as the fifth fund granted by STIFA and the seventh grant in total that the Research Center has been awarded in the last three years.
For more information about our previous research grants, please visit the Research Center page: https://bit.ly/3axpQoV